SCHEMBL22134366

SCHEMBL22134366

CCCC1CCC(C(=O)NCCNC)CC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NAAA Q02083 1/20 0.45
CYP1A2 P05177 1/20 0.43
CYP2D6 P10635 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
GNAI3 P08754 1/20 0.42
GNAO1 P09471 1/20 0.42
GNAI1 P63096 1/20 0.42
ALDH1A1 P00352 1/20 0.40
LMNA P02545 1/20 0.40
TP53 P04637 1/20 0.40
KMT2A Q03164 2/20 0.39
THRB P10828 1/20 0.39
MEN1 O00255 1/20 0.39
HSD17B10 Q99714 2/20 0.39
KDM4E B2RXH2 2/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
MAPT P10636 1/20 0.38
CHRNB2 P17787 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18738914 0.83 THRB (0.47) NAAACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL18179835 0.82 CYP1A2 (0.55) NAAACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL7740128 0.80 NAAA (0.49) NAAACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL7740129 0.80 NAAA (0.49) NAAACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL12895188 0.79 NAAA (0.42) NAAAGNAI3GNAO1GNAI1KMT2A
SCHEMBL24098150 0.78 NAAA (0.68) NAAACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL7739482 0.78 NAAA (0.48) NAAACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL7739487 0.78 NAAA (0.48) NAAACYP1A2CYP2D6CYP2C9CYP2C19
SCHEMBL21078257 0.77 NAAA (0.61) NAAAALDH1A1KMT2ATHRBMEN1
SCHEMBL103494 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3432934-B1 PRODRUGS OF CYTOTOXIC AGENTS WITH ENZYMATICALLY CLEAVABLE GROUPS Bayer Pharma AG (DE) 2022-02-23 EP disclosed
EP-3086814-B1 DRUG CONJUGATES (ADCS) WITH KINESIN SPINDEL PROTEIN (KSP) Bayer Pharma AG (DE) 2020-06-24 EP disclosed